nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—SLCO1B3—Rosuvastatin—atherosclerosis	0.0664	0.1	CbGbCtD
Docetaxel—SLCO1B3—Pravastatin—atherosclerosis	0.0604	0.0911	CbGbCtD
Docetaxel—SLC22A7—Pravastatin—atherosclerosis	0.0532	0.0802	CbGbCtD
Docetaxel—ABCC1—Rosuvastatin—atherosclerosis	0.0459	0.0692	CbGbCtD
Docetaxel—ABCC2—Ezetimibe—atherosclerosis	0.034	0.0512	CbGbCtD
Docetaxel—ABCC2—Simvastatin—atherosclerosis	0.0316	0.0476	CbGbCtD
Docetaxel—ABCC2—Pravastatin—atherosclerosis	0.0309	0.0466	CbGbCtD
Docetaxel—ABCC2—Lovastatin—atherosclerosis	0.0309	0.0466	CbGbCtD
Docetaxel—ABCG2—Rosuvastatin—atherosclerosis	0.0307	0.0463	CbGbCtD
Docetaxel—ABCG2—Ezetimibe—atherosclerosis	0.0307	0.0463	CbGbCtD
Docetaxel—ABCG2—Pravastatin—atherosclerosis	0.028	0.0421	CbGbCtD
Docetaxel—CYP3A7—Simvastatin—atherosclerosis	0.0211	0.0318	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0211	0.0318	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.0207	0.0311	CbGbCtD
Docetaxel—CYP3A7—Lovastatin—atherosclerosis	0.0207	0.0311	CbGbCtD
Docetaxel—CYP3A5—Rosuvastatin—atherosclerosis	0.017	0.0257	CbGbCtD
Docetaxel—CYP3A5—Simvastatin—atherosclerosis	0.0158	0.0239	CbGbCtD
Docetaxel—CYP3A5—Lovastatin—atherosclerosis	0.0155	0.0234	CbGbCtD
Docetaxel—CYP3A5—Pravastatin—atherosclerosis	0.0155	0.0234	CbGbCtD
Docetaxel—MAP2—middle cerebral artery—atherosclerosis	0.0126	0.278	CbGeAlD
Docetaxel—ABCB1—Ezetimibe—atherosclerosis	0.0111	0.0167	CbGbCtD
Docetaxel—ABCB1—Simvastatin—atherosclerosis	0.0103	0.0155	CbGbCtD
Docetaxel—ABCB1—Lovastatin—atherosclerosis	0.0101	0.0152	CbGbCtD
Docetaxel—ABCB1—Pravastatin—atherosclerosis	0.0101	0.0152	CbGbCtD
Docetaxel—CYP3A4—Rosuvastatin—atherosclerosis	0.00664	0.01	CbGbCtD
Docetaxel—CYP3A4—Ezetimibe—atherosclerosis	0.00664	0.01	CbGbCtD
Docetaxel—CYP3A4—Simvastatin—atherosclerosis	0.00617	0.00931	CbGbCtD
Docetaxel—CYP3A4—Lovastatin—atherosclerosis	0.00604	0.00911	CbGbCtD
Docetaxel—CYP3A4—Pravastatin—atherosclerosis	0.00604	0.00911	CbGbCtD
Docetaxel—TUBB3—connective tissue—atherosclerosis	0.00136	0.0302	CbGeAlD
Docetaxel—MAP4—connective tissue—atherosclerosis	0.00136	0.0302	CbGeAlD
Docetaxel—MAPT—adipose tissue—atherosclerosis	0.00133	0.0294	CbGeAlD
Docetaxel—BCL2—connective tissue—atherosclerosis	0.00124	0.0274	CbGeAlD
Docetaxel—MAP4—cardiovascular system—atherosclerosis	0.00119	0.0262	CbGeAlD
Docetaxel—NR1I2—liver—atherosclerosis	0.00112	0.0248	CbGeAlD
Docetaxel—BCL2—cardiovascular system—atherosclerosis	0.00108	0.0239	CbGeAlD
Docetaxel—MAP4—adipose tissue—atherosclerosis	0.00105	0.0231	CbGeAlD
Docetaxel—TUBB1—adipose tissue—atherosclerosis	0.00102	0.0226	CbGeAlD
Docetaxel—TUBB6—Pimozide—Ezetimibe—atherosclerosis	0.00102	0.288	CbGdCrCtD
Docetaxel—EGFR—adipose tissue—atherosclerosis	0.000939	0.0208	CbGeAlD
Docetaxel—MAP2—cardiovascular system—atherosclerosis	0.000933	0.0207	CbGeAlD
Docetaxel—TUBB6—Fluvastatin—Rosuvastatin—atherosclerosis	0.000863	0.244	CbGdCrCtD
Docetaxel—TUBB4A—connective tissue—atherosclerosis	0.000829	0.0184	CbGeAlD
Docetaxel—TUBB6—Simvastatin—Pravastatin—atherosclerosis	0.000825	0.234	CbGdCrCtD
Docetaxel—TUBB6—Simvastatin—Lovastatin—atherosclerosis	0.000825	0.234	CbGdCrCtD
Docetaxel—MAP2—adipose tissue—atherosclerosis	0.000823	0.0182	CbGeAlD
Docetaxel—TUBB2B—connective tissue—atherosclerosis	0.000801	0.0177	CbGeAlD
Docetaxel—TUBB2A—connective tissue—atherosclerosis	0.000754	0.0167	CbGeAlD
Docetaxel—MAP4—liver—atherosclerosis	0.000733	0.0162	CbGeAlD
Docetaxel—TUBB4A—cardiovascular system—atherosclerosis	0.000721	0.016	CbGeAlD
Docetaxel—EGFR—liver—atherosclerosis	0.000658	0.0146	CbGeAlD
Docetaxel—TUBB6—cardiovascular system—atherosclerosis	0.000647	0.0143	CbGeAlD
Docetaxel—TUBB4B—connective tissue—atherosclerosis	0.000647	0.0143	CbGeAlD
Docetaxel—SLCO1B3—liver—atherosclerosis	0.000642	0.0142	CbGeAlD
Docetaxel—TUBB2B—adipose tissue—atherosclerosis	0.000615	0.0136	CbGeAlD
Docetaxel—TUBB—adipose tissue—atherosclerosis	0.000582	0.0129	CbGeAlD
Docetaxel—TUBB2A—adipose tissue—atherosclerosis	0.000579	0.0128	CbGeAlD
Docetaxel—MAP2—liver—atherosclerosis	0.000577	0.0128	CbGeAlD
Docetaxel—TUBB6—adipose tissue—atherosclerosis	0.000571	0.0126	CbGeAlD
Docetaxel—TUBB4B—cardiovascular system—atherosclerosis	0.000563	0.0125	CbGeAlD
Docetaxel—CYP3A7—liver—atherosclerosis	0.000541	0.012	CbGeAlD
Docetaxel—CYP1B1—connective tissue—atherosclerosis	0.000512	0.0113	CbGeAlD
Docetaxel—ABCC10—adipose tissue—atherosclerosis	0.0005	0.0111	CbGeAlD
Docetaxel—SLC22A7—liver—atherosclerosis	0.000499	0.0111	CbGeAlD
Docetaxel—TUBB4B—adipose tissue—atherosclerosis	0.000496	0.011	CbGeAlD
Docetaxel—CYP3A7-CYP3A51P—liver—atherosclerosis	0.00046	0.0102	CbGeAlD
Docetaxel—TUBB4A—liver—atherosclerosis	0.000446	0.00988	CbGeAlD
Docetaxel—CYP1B1—cardiovascular system—atherosclerosis	0.000446	0.00987	CbGeAlD
Docetaxel—TUBB—liver—atherosclerosis	0.000408	0.00904	CbGeAlD
Docetaxel—TUBB2A—liver—atherosclerosis	0.000406	0.00899	CbGeAlD
Docetaxel—TUBB6—liver—atherosclerosis	0.0004	0.00886	CbGeAlD
Docetaxel—CYP1B1—adipose tissue—atherosclerosis	0.000393	0.0087	CbGeAlD
Docetaxel—ABCB1—blood vessel—atherosclerosis	0.000367	0.00812	CbGeAlD
Docetaxel—ABCC1—adipose tissue—atherosclerosis	0.000353	0.00783	CbGeAlD
Docetaxel—ABCC10—liver—atherosclerosis	0.00035	0.00776	CbGeAlD
Docetaxel—TUBB4B—liver—atherosclerosis	0.000348	0.00771	CbGeAlD
Docetaxel—Arthralgia—Rosuvastatin—atherosclerosis	0.000318	0.0021	CcSEcCtD
Docetaxel—Myalgia—Rosuvastatin—atherosclerosis	0.000318	0.0021	CcSEcCtD
Docetaxel—Flushing—Simvastatin—atherosclerosis	0.000315	0.00208	CcSEcCtD
Docetaxel—Alopecia—Ezetimibe—atherosclerosis	0.000315	0.00208	CcSEcCtD
Docetaxel—Haemoglobin—Niacin—atherosclerosis	0.000314	0.00207	CcSEcCtD
Docetaxel—Rhinitis—Niacin—atherosclerosis	0.000313	0.00207	CcSEcCtD
Docetaxel—Mental disorder—Ezetimibe—atherosclerosis	0.000312	0.00206	CcSEcCtD
Docetaxel—Haemorrhage—Niacin—atherosclerosis	0.000312	0.00206	CcSEcCtD
Docetaxel—Hepatitis—Niacin—atherosclerosis	0.000312	0.00206	CcSEcCtD
Docetaxel—Hypoaesthesia—Niacin—atherosclerosis	0.00031	0.00205	CcSEcCtD
Docetaxel—Erythema—Ezetimibe—atherosclerosis	0.00031	0.00205	CcSEcCtD
Docetaxel—Malnutrition—Ezetimibe—atherosclerosis	0.00031	0.00205	CcSEcCtD
Docetaxel—Dysgeusia—Lovastatin—atherosclerosis	0.00031	0.00205	CcSEcCtD
Docetaxel—Rhinitis—Pravastatin—atherosclerosis	0.000308	0.00204	CcSEcCtD
Docetaxel—Oedema peripheral—Niacin—atherosclerosis	0.000307	0.00203	CcSEcCtD
Docetaxel—Hepatitis—Pravastatin—atherosclerosis	0.000307	0.00203	CcSEcCtD
Docetaxel—Confusional state—Rosuvastatin—atherosclerosis	0.000307	0.00203	CcSEcCtD
Docetaxel—Back pain—Lovastatin—atherosclerosis	0.000306	0.00202	CcSEcCtD
Docetaxel—Hypoaesthesia—Pravastatin—atherosclerosis	0.000306	0.00202	CcSEcCtD
Docetaxel—Pharyngitis—Pravastatin—atherosclerosis	0.000305	0.00201	CcSEcCtD
Docetaxel—Chills—Simvastatin—atherosclerosis	0.000305	0.00201	CcSEcCtD
Docetaxel—Muscle spasms—Lovastatin—atherosclerosis	0.000304	0.00201	CcSEcCtD
Docetaxel—Infection—Rosuvastatin—atherosclerosis	0.000303	0.002	CcSEcCtD
Docetaxel—Visual impairment—Niacin—atherosclerosis	0.000301	0.00199	CcSEcCtD
Docetaxel—Alopecia—Simvastatin—atherosclerosis	0.0003	0.00198	CcSEcCtD
Docetaxel—Back pain—Ezetimibe—atherosclerosis	0.0003	0.00198	CcSEcCtD
Docetaxel—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000299	0.00197	CcSEcCtD
Docetaxel—Muscle spasms—Ezetimibe—atherosclerosis	0.000298	0.00197	CcSEcCtD
Docetaxel—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000298	0.00197	CcSEcCtD
Docetaxel—Mental disorder—Simvastatin—atherosclerosis	0.000298	0.00197	CcSEcCtD
Docetaxel—Visual impairment—Pravastatin—atherosclerosis	0.000296	0.00196	CcSEcCtD
Docetaxel—Erythema—Simvastatin—atherosclerosis	0.000296	0.00195	CcSEcCtD
Docetaxel—ABCG2—adipose tissue—atherosclerosis	0.000293	0.00648	CbGeAlD
Docetaxel—Eye disorder—Niacin—atherosclerosis	0.000292	0.00193	CcSEcCtD
Docetaxel—Erythema multiforme—Pravastatin—atherosclerosis	0.00029	0.00192	CcSEcCtD
Docetaxel—Dysgeusia—Simvastatin—atherosclerosis	0.00029	0.00191	CcSEcCtD
Docetaxel—Flushing—Niacin—atherosclerosis	0.00029	0.00191	CcSEcCtD
Docetaxel—Anaemia—Ezetimibe—atherosclerosis	0.000287	0.00189	CcSEcCtD
Docetaxel—Flushing—Pravastatin—atherosclerosis	0.000285	0.00188	CcSEcCtD
Docetaxel—Cardiac disorder—Pravastatin—atherosclerosis	0.000285	0.00188	CcSEcCtD
Docetaxel—Muscle spasms—Simvastatin—atherosclerosis	0.000284	0.00188	CcSEcCtD
Docetaxel—Angiopathy—Niacin—atherosclerosis	0.000283	0.00187	CcSEcCtD
Docetaxel—Leukopenia—Lovastatin—atherosclerosis	0.000283	0.00187	CcSEcCtD
Docetaxel—ABCC2—liver—atherosclerosis	0.000281	0.00623	CbGeAlD
Docetaxel—Chills—Niacin—atherosclerosis	0.00028	0.00185	CcSEcCtD
Docetaxel—Arrhythmia—Niacin—atherosclerosis	0.000279	0.00184	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000278	0.00183	CcSEcCtD
Docetaxel—Alopecia—Niacin—atherosclerosis	0.000276	0.00182	CcSEcCtD
Docetaxel—Chills—Pravastatin—atherosclerosis	0.000276	0.00182	CcSEcCtD
Docetaxel—CYP1B1—liver—atherosclerosis	0.000276	0.0061	CbGeAlD
Docetaxel—Insomnia—Rosuvastatin—atherosclerosis	0.000275	0.00182	CcSEcCtD
Docetaxel—Arrhythmia—Pravastatin—atherosclerosis	0.000274	0.00181	CcSEcCtD
Docetaxel—Palpitations—Ezetimibe—atherosclerosis	0.000274	0.00181	CcSEcCtD
Docetaxel—Paraesthesia—Rosuvastatin—atherosclerosis	0.000274	0.00181	CcSEcCtD
Docetaxel—Anaemia—Simvastatin—atherosclerosis	0.000273	0.00181	CcSEcCtD
Docetaxel—Malnutrition—Niacin—atherosclerosis	0.000272	0.00179	CcSEcCtD
Docetaxel—Erythema—Niacin—atherosclerosis	0.000272	0.00179	CcSEcCtD
Docetaxel—CYP3A5—adipose tissue—atherosclerosis	0.000272	0.00602	CbGeAlD
Docetaxel—Alopecia—Pravastatin—atherosclerosis	0.000271	0.00179	CcSEcCtD
Docetaxel—Cough—Ezetimibe—atherosclerosis	0.000271	0.00179	CcSEcCtD
Docetaxel—Arthralgia—Lovastatin—atherosclerosis	0.000269	0.00178	CcSEcCtD
Docetaxel—Myalgia—Lovastatin—atherosclerosis	0.000269	0.00178	CcSEcCtD
Docetaxel—Chest pain—Lovastatin—atherosclerosis	0.000269	0.00178	CcSEcCtD
Docetaxel—Dyspepsia—Rosuvastatin—atherosclerosis	0.000268	0.00177	CcSEcCtD
Docetaxel—Hypertension—Ezetimibe—atherosclerosis	0.000268	0.00177	CcSEcCtD
Docetaxel—Leukopenia—Simvastatin—atherosclerosis	0.000265	0.00175	CcSEcCtD
Docetaxel—Arthralgia—Ezetimibe—atherosclerosis	0.000264	0.00175	CcSEcCtD
Docetaxel—Myalgia—Ezetimibe—atherosclerosis	0.000264	0.00175	CcSEcCtD
Docetaxel—Chest pain—Ezetimibe—atherosclerosis	0.000264	0.00175	CcSEcCtD
Docetaxel—Dry mouth—Lovastatin—atherosclerosis	0.000263	0.00174	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000262	0.00173	CcSEcCtD
Docetaxel—Dysgeusia—Pravastatin—atherosclerosis	0.000262	0.00173	CcSEcCtD
Docetaxel—Muscle spasms—Niacin—atherosclerosis	0.000261	0.00173	CcSEcCtD
Docetaxel—Constipation—Rosuvastatin—atherosclerosis	0.00026	0.00172	CcSEcCtD
Docetaxel—Pain—Rosuvastatin—atherosclerosis	0.00026	0.00172	CcSEcCtD
Docetaxel—Confusional state—Lovastatin—atherosclerosis	0.00026	0.00172	CcSEcCtD
Docetaxel—Dry mouth—Ezetimibe—atherosclerosis	0.000258	0.00171	CcSEcCtD
Docetaxel—Anaphylactic shock—Lovastatin—atherosclerosis	0.000258	0.00171	CcSEcCtD
Docetaxel—Muscle spasms—Pravastatin—atherosclerosis	0.000257	0.0017	CcSEcCtD
Docetaxel—Infection—Lovastatin—atherosclerosis	0.000256	0.00169	CcSEcCtD
Docetaxel—Confusional state—Ezetimibe—atherosclerosis	0.000255	0.00169	CcSEcCtD
Docetaxel—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000253	0.00167	CcSEcCtD
Docetaxel—Thrombocytopenia—Lovastatin—atherosclerosis	0.000253	0.00167	CcSEcCtD
Docetaxel—Myalgia—Simvastatin—atherosclerosis	0.000252	0.00166	CcSEcCtD
Docetaxel—Arthralgia—Simvastatin—atherosclerosis	0.000252	0.00166	CcSEcCtD
Docetaxel—Chest pain—Simvastatin—atherosclerosis	0.000252	0.00166	CcSEcCtD
Docetaxel—Infection—Ezetimibe—atherosclerosis	0.000252	0.00166	CcSEcCtD
Docetaxel—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000251	0.00166	CcSEcCtD
Docetaxel—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000249	0.00165	CcSEcCtD
Docetaxel—Nervous system disorder—Ezetimibe—atherosclerosis	0.000248	0.00164	CcSEcCtD
Docetaxel—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000248	0.00164	CcSEcCtD
Docetaxel—ABCC1—liver—atherosclerosis	0.000248	0.00549	CbGeAlD
Docetaxel—Anaemia—Pravastatin—atherosclerosis	0.000247	0.00163	CcSEcCtD
Docetaxel—Anorexia—Lovastatin—atherosclerosis	0.000246	0.00163	CcSEcCtD
Docetaxel—Skin disorder—Ezetimibe—atherosclerosis	0.000246	0.00162	CcSEcCtD
Docetaxel—Syncope—Niacin—atherosclerosis	0.000244	0.00161	CcSEcCtD
Docetaxel—Confusional state—Simvastatin—atherosclerosis	0.000243	0.00161	CcSEcCtD
Docetaxel—Leukopenia—Niacin—atherosclerosis	0.000243	0.00161	CcSEcCtD
Docetaxel—Anaphylactic shock—Simvastatin—atherosclerosis	0.000241	0.0016	CcSEcCtD
Docetaxel—Oedema—Simvastatin—atherosclerosis	0.000241	0.0016	CcSEcCtD
Docetaxel—Abdominal pain—Rosuvastatin—atherosclerosis	0.000241	0.00159	CcSEcCtD
Docetaxel—Palpitations—Niacin—atherosclerosis	0.00024	0.00159	CcSEcCtD
Docetaxel—Infection—Simvastatin—atherosclerosis	0.00024	0.00158	CcSEcCtD
Docetaxel—Leukopenia—Pravastatin—atherosclerosis	0.000239	0.00158	CcSEcCtD
Docetaxel—Loss of consciousness—Niacin—atherosclerosis	0.000239	0.00158	CcSEcCtD
Docetaxel—Cough—Niacin—atherosclerosis	0.000237	0.00157	CcSEcCtD
Docetaxel—Thrombocytopenia—Simvastatin—atherosclerosis	0.000236	0.00156	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000235	0.00155	CcSEcCtD
Docetaxel—Insomnia—Lovastatin—atherosclerosis	0.000233	0.00154	CcSEcCtD
Docetaxel—Cough—Pravastatin—atherosclerosis	0.000233	0.00154	CcSEcCtD
Docetaxel—Paraesthesia—Lovastatin—atherosclerosis	0.000232	0.00153	CcSEcCtD
Docetaxel—Arthralgia—Niacin—atherosclerosis	0.000231	0.00153	CcSEcCtD
Docetaxel—Myalgia—Niacin—atherosclerosis	0.000231	0.00153	CcSEcCtD
Docetaxel—Hypertension—Pravastatin—atherosclerosis	0.000231	0.00153	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000231	0.00152	CcSEcCtD
Docetaxel—Anorexia—Simvastatin—atherosclerosis	0.00023	0.00152	CcSEcCtD
Docetaxel—Dyspnoea—Lovastatin—atherosclerosis	0.00023	0.00152	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00023	0.00152	CcSEcCtD
Docetaxel—Insomnia—Ezetimibe—atherosclerosis	0.000229	0.00151	CcSEcCtD
Docetaxel—Arthralgia—Pravastatin—atherosclerosis	0.000228	0.0015	CcSEcCtD
Docetaxel—Chest pain—Pravastatin—atherosclerosis	0.000228	0.0015	CcSEcCtD
Docetaxel—Myalgia—Pravastatin—atherosclerosis	0.000228	0.0015	CcSEcCtD
Docetaxel—Paraesthesia—Ezetimibe—atherosclerosis	0.000227	0.0015	CcSEcCtD
Docetaxel—Dyspepsia—Lovastatin—atherosclerosis	0.000227	0.0015	CcSEcCtD
Docetaxel—Dry mouth—Niacin—atherosclerosis	0.000226	0.00149	CcSEcCtD
Docetaxel—Dyspnoea—Ezetimibe—atherosclerosis	0.000226	0.00149	CcSEcCtD
Docetaxel—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000224	0.00148	CcSEcCtD
Docetaxel—Decreased appetite—Lovastatin—atherosclerosis	0.000224	0.00148	CcSEcCtD
Docetaxel—Dyspepsia—Ezetimibe—atherosclerosis	0.000223	0.00147	CcSEcCtD
Docetaxel—Fatigue—Lovastatin—atherosclerosis	0.000223	0.00147	CcSEcCtD
Docetaxel—Anaphylactic shock—Niacin—atherosclerosis	0.000222	0.00146	CcSEcCtD
Docetaxel—Oedema—Niacin—atherosclerosis	0.000222	0.00146	CcSEcCtD
Docetaxel—Constipation—Lovastatin—atherosclerosis	0.000221	0.00146	CcSEcCtD
Docetaxel—Pain—Lovastatin—atherosclerosis	0.000221	0.00146	CcSEcCtD
Docetaxel—Confusional state—Pravastatin—atherosclerosis	0.00022	0.00145	CcSEcCtD
Docetaxel—Decreased appetite—Ezetimibe—atherosclerosis	0.00022	0.00145	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00022	0.00145	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000219	0.00144	CcSEcCtD
Docetaxel—Asthenia—Rosuvastatin—atherosclerosis	0.000219	0.00144	CcSEcCtD
Docetaxel—Insomnia—Simvastatin—atherosclerosis	0.000218	0.00144	CcSEcCtD
Docetaxel—Anaphylactic shock—Pravastatin—atherosclerosis	0.000218	0.00144	CcSEcCtD
Docetaxel—Oedema—Pravastatin—atherosclerosis	0.000218	0.00144	CcSEcCtD
Docetaxel—Fatigue—Ezetimibe—atherosclerosis	0.000218	0.00144	CcSEcCtD
Docetaxel—Shock—Niacin—atherosclerosis	0.000218	0.00144	CcSEcCtD
Docetaxel—Infection—Pravastatin—atherosclerosis	0.000217	0.00143	CcSEcCtD
Docetaxel—Paraesthesia—Simvastatin—atherosclerosis	0.000217	0.00143	CcSEcCtD
Docetaxel—Pain—Ezetimibe—atherosclerosis	0.000217	0.00143	CcSEcCtD
Docetaxel—Constipation—Ezetimibe—atherosclerosis	0.000217	0.00143	CcSEcCtD
Docetaxel—Tachycardia—Niacin—atherosclerosis	0.000216	0.00143	CcSEcCtD
Docetaxel—Pruritus—Rosuvastatin—atherosclerosis	0.000215	0.00142	CcSEcCtD
Docetaxel—Skin disorder—Niacin—atherosclerosis	0.000215	0.00142	CcSEcCtD
Docetaxel—Dyspnoea—Simvastatin—atherosclerosis	0.000215	0.00142	CcSEcCtD
Docetaxel—Thrombocytopenia—Pravastatin—atherosclerosis	0.000214	0.00141	CcSEcCtD
Docetaxel—Feeling abnormal—Lovastatin—atherosclerosis	0.000213	0.00141	CcSEcCtD
Docetaxel—Dyspepsia—Simvastatin—atherosclerosis	0.000213	0.0014	CcSEcCtD
Docetaxel—Anorexia—Niacin—atherosclerosis	0.000211	0.0014	CcSEcCtD
Docetaxel—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000211	0.00139	CcSEcCtD
Docetaxel—Decreased appetite—Simvastatin—atherosclerosis	0.00021	0.00139	CcSEcCtD
Docetaxel—Feeling abnormal—Ezetimibe—atherosclerosis	0.000209	0.00138	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000208	0.00138	CcSEcCtD
Docetaxel—Diarrhoea—Rosuvastatin—atherosclerosis	0.000208	0.00138	CcSEcCtD
Docetaxel—Fatigue—Simvastatin—atherosclerosis	0.000208	0.00138	CcSEcCtD
Docetaxel—Anorexia—Pravastatin—atherosclerosis	0.000208	0.00137	CcSEcCtD
Docetaxel—Hypotension—Niacin—atherosclerosis	0.000207	0.00137	CcSEcCtD
Docetaxel—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000207	0.00137	CcSEcCtD
Docetaxel—Constipation—Simvastatin—atherosclerosis	0.000206	0.00136	CcSEcCtD
Docetaxel—Pain—Simvastatin—atherosclerosis	0.000206	0.00136	CcSEcCtD
Docetaxel—ABCG2—liver—atherosclerosis	0.000205	0.00454	CbGeAlD
Docetaxel—Abdominal pain—Lovastatin—atherosclerosis	0.000204	0.00135	CcSEcCtD
Docetaxel—Body temperature increased—Lovastatin—atherosclerosis	0.000204	0.00135	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000202	0.00133	CcSEcCtD
Docetaxel—Dizziness—Rosuvastatin—atherosclerosis	0.000201	0.00133	CcSEcCtD
Docetaxel—Insomnia—Niacin—atherosclerosis	0.000201	0.00132	CcSEcCtD
Docetaxel—Abdominal pain—Ezetimibe—atherosclerosis	0.0002	0.00132	CcSEcCtD
Docetaxel—Body temperature increased—Ezetimibe—atherosclerosis	0.0002	0.00132	CcSEcCtD
Docetaxel—Paraesthesia—Niacin—atherosclerosis	0.000199	0.00132	CcSEcCtD
Docetaxel—Feeling abnormal—Simvastatin—atherosclerosis	0.000199	0.00131	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000199	0.00131	CcSEcCtD
Docetaxel—Dyspnoea—Niacin—atherosclerosis	0.000198	0.00131	CcSEcCtD
Docetaxel—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000197	0.0013	CcSEcCtD
Docetaxel—Insomnia—Pravastatin—atherosclerosis	0.000197	0.0013	CcSEcCtD
Docetaxel—Somnolence—Niacin—atherosclerosis	0.000197	0.0013	CcSEcCtD
Docetaxel—Paraesthesia—Pravastatin—atherosclerosis	0.000196	0.0013	CcSEcCtD
Docetaxel—Dyspepsia—Niacin—atherosclerosis	0.000195	0.00129	CcSEcCtD
Docetaxel—Dyspnoea—Pravastatin—atherosclerosis	0.000195	0.00129	CcSEcCtD
Docetaxel—Decreased appetite—Niacin—atherosclerosis	0.000193	0.00127	CcSEcCtD
Docetaxel—Dyspepsia—Pravastatin—atherosclerosis	0.000192	0.00127	CcSEcCtD
Docetaxel—Rash—Rosuvastatin—atherosclerosis	0.000192	0.00127	CcSEcCtD
Docetaxel—Dermatitis—Rosuvastatin—atherosclerosis	0.000192	0.00127	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Niacin—atherosclerosis	0.000191	0.00126	CcSEcCtD
Docetaxel—Abdominal pain—Simvastatin—atherosclerosis	0.000191	0.00126	CcSEcCtD
Docetaxel—Body temperature increased—Simvastatin—atherosclerosis	0.000191	0.00126	CcSEcCtD
Docetaxel—Headache—Rosuvastatin—atherosclerosis	0.000191	0.00126	CcSEcCtD
Docetaxel—CYP3A5—liver—atherosclerosis	0.00019	0.00422	CbGeAlD
Docetaxel—Hypersensitivity—Lovastatin—atherosclerosis	0.00019	0.00126	CcSEcCtD
Docetaxel—Decreased appetite—Pravastatin—atherosclerosis	0.00019	0.00125	CcSEcCtD
Docetaxel—Pain—Niacin—atherosclerosis	0.00019	0.00125	CcSEcCtD
Docetaxel—Fatigue—Pravastatin—atherosclerosis	0.000188	0.00124	CcSEcCtD
Docetaxel—Pain—Pravastatin—atherosclerosis	0.000187	0.00123	CcSEcCtD
Docetaxel—Constipation—Pravastatin—atherosclerosis	0.000187	0.00123	CcSEcCtD
Docetaxel—Hypersensitivity—Ezetimibe—atherosclerosis	0.000187	0.00123	CcSEcCtD
Docetaxel—Asthenia—Lovastatin—atherosclerosis	0.000185	0.00122	CcSEcCtD
Docetaxel—Pruritus—Lovastatin—atherosclerosis	0.000183	0.00121	CcSEcCtD
Docetaxel—Asthenia—Ezetimibe—atherosclerosis	0.000182	0.0012	CcSEcCtD
Docetaxel—Gastrointestinal pain—Niacin—atherosclerosis	0.000181	0.0012	CcSEcCtD
Docetaxel—Nausea—Rosuvastatin—atherosclerosis	0.000181	0.0012	CcSEcCtD
Docetaxel—Feeling abnormal—Pravastatin—atherosclerosis	0.00018	0.00119	CcSEcCtD
Docetaxel—Pruritus—Ezetimibe—atherosclerosis	0.000179	0.00118	CcSEcCtD
Docetaxel—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000178	0.00118	CcSEcCtD
Docetaxel—Hypersensitivity—Simvastatin—atherosclerosis	0.000178	0.00118	CcSEcCtD
Docetaxel—Diarrhoea—Lovastatin—atherosclerosis	0.000177	0.00117	CcSEcCtD
Docetaxel—Body temperature increased—Niacin—atherosclerosis	0.000175	0.00116	CcSEcCtD
Docetaxel—Abdominal pain—Niacin—atherosclerosis	0.000175	0.00116	CcSEcCtD
Docetaxel—Asthenia—Simvastatin—atherosclerosis	0.000173	0.00114	CcSEcCtD
Docetaxel—Diarrhoea—Ezetimibe—atherosclerosis	0.000173	0.00114	CcSEcCtD
Docetaxel—Body temperature increased—Pravastatin—atherosclerosis	0.000173	0.00114	CcSEcCtD
Docetaxel—Abdominal pain—Pravastatin—atherosclerosis	0.000173	0.00114	CcSEcCtD
Docetaxel—Pruritus—Simvastatin—atherosclerosis	0.000171	0.00113	CcSEcCtD
Docetaxel—Dizziness—Lovastatin—atherosclerosis	0.000171	0.00113	CcSEcCtD
Docetaxel—Dizziness—Ezetimibe—atherosclerosis	0.000167	0.00111	CcSEcCtD
Docetaxel—Diarrhoea—Simvastatin—atherosclerosis	0.000165	0.00109	CcSEcCtD
Docetaxel—Vomiting—Lovastatin—atherosclerosis	0.000164	0.00108	CcSEcCtD
Docetaxel—ABCB1—cardiovascular system—atherosclerosis	0.000164	0.00362	CbGeAlD
Docetaxel—Hypersensitivity—Niacin—atherosclerosis	0.000163	0.00108	CcSEcCtD
Docetaxel—Rash—Lovastatin—atherosclerosis	0.000163	0.00108	CcSEcCtD
Docetaxel—Dermatitis—Lovastatin—atherosclerosis	0.000163	0.00107	CcSEcCtD
Docetaxel—Headache—Lovastatin—atherosclerosis	0.000162	0.00107	CcSEcCtD
Docetaxel—Vomiting—Ezetimibe—atherosclerosis	0.000161	0.00106	CcSEcCtD
Docetaxel—Hypersensitivity—Pravastatin—atherosclerosis	0.000161	0.00106	CcSEcCtD
Docetaxel—Dizziness—Simvastatin—atherosclerosis	0.00016	0.00105	CcSEcCtD
Docetaxel—Rash—Ezetimibe—atherosclerosis	0.00016	0.00105	CcSEcCtD
Docetaxel—Dermatitis—Ezetimibe—atherosclerosis	0.000159	0.00105	CcSEcCtD
Docetaxel—Asthenia—Niacin—atherosclerosis	0.000159	0.00105	CcSEcCtD
Docetaxel—Headache—Ezetimibe—atherosclerosis	0.000159	0.00105	CcSEcCtD
Docetaxel—Pruritus—Niacin—atherosclerosis	0.000157	0.00104	CcSEcCtD
Docetaxel—Asthenia—Pravastatin—atherosclerosis	0.000157	0.00103	CcSEcCtD
Docetaxel—Pruritus—Pravastatin—atherosclerosis	0.000154	0.00102	CcSEcCtD
Docetaxel—Vomiting—Simvastatin—atherosclerosis	0.000154	0.00101	CcSEcCtD
Docetaxel—Nausea—Lovastatin—atherosclerosis	0.000153	0.00101	CcSEcCtD
Docetaxel—Rash—Simvastatin—atherosclerosis	0.000152	0.00101	CcSEcCtD
Docetaxel—Dermatitis—Simvastatin—atherosclerosis	0.000152	0.001	CcSEcCtD
Docetaxel—Diarrhoea—Niacin—atherosclerosis	0.000152	0.001	CcSEcCtD
Docetaxel—Headache—Simvastatin—atherosclerosis	0.000151	0.000999	CcSEcCtD
Docetaxel—Nausea—Ezetimibe—atherosclerosis	0.00015	0.000994	CcSEcCtD
Docetaxel—Diarrhoea—Pravastatin—atherosclerosis	0.000149	0.000987	CcSEcCtD
Docetaxel—Dizziness—Niacin—atherosclerosis	0.000147	0.000969	CcSEcCtD
Docetaxel—Dizziness—Pravastatin—atherosclerosis	0.000144	0.000954	CcSEcCtD
Docetaxel—ABCB1—adipose tissue—atherosclerosis	0.000144	0.0032	CbGeAlD
Docetaxel—Nausea—Simvastatin—atherosclerosis	0.000143	0.000948	CcSEcCtD
Docetaxel—CYP3A4—liver—atherosclerosis	0.000143	0.00317	CbGeAlD
Docetaxel—Vomiting—Niacin—atherosclerosis	0.000141	0.000931	CcSEcCtD
Docetaxel—Rash—Niacin—atherosclerosis	0.00014	0.000924	CcSEcCtD
Docetaxel—Dermatitis—Niacin—atherosclerosis	0.00014	0.000923	CcSEcCtD
Docetaxel—Headache—Niacin—atherosclerosis	0.000139	0.000918	CcSEcCtD
Docetaxel—Vomiting—Pravastatin—atherosclerosis	0.000139	0.000917	CcSEcCtD
Docetaxel—Rash—Pravastatin—atherosclerosis	0.000138	0.000909	CcSEcCtD
Docetaxel—Dermatitis—Pravastatin—atherosclerosis	0.000138	0.000909	CcSEcCtD
Docetaxel—Headache—Pravastatin—atherosclerosis	0.000137	0.000904	CcSEcCtD
Docetaxel—Nausea—Niacin—atherosclerosis	0.000132	0.00087	CcSEcCtD
Docetaxel—Nausea—Pravastatin—atherosclerosis	0.00013	0.000857	CcSEcCtD
Docetaxel—ABCB1—liver—atherosclerosis	0.000101	0.00224	CbGeAlD
Docetaxel—ABCB1—Metabolism—BGN—atherosclerosis	6.1e-06	4.47e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CD36—atherosclerosis	6.1e-06	4.46e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—GPX1—atherosclerosis	6.06e-06	4.43e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—APOE—atherosclerosis	6.05e-06	4.43e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—APOA5—atherosclerosis	6.04e-06	4.42e-05	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—AKT1—atherosclerosis	6.04e-06	4.42e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CCL2—atherosclerosis	6.03e-06	4.42e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CAV1—atherosclerosis	6e-06	4.39e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PLG—atherosclerosis	5.99e-06	4.39e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NOS2—atherosclerosis	5.99e-06	4.38e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—APOA1—atherosclerosis	5.98e-06	4.38e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—ALB—atherosclerosis	5.96e-06	4.36e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—STAT3—atherosclerosis	5.93e-06	4.34e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—APOB—atherosclerosis	5.91e-06	4.33e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CD36—atherosclerosis	5.9e-06	4.32e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—TNF—atherosclerosis	5.9e-06	4.32e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—APOB—atherosclerosis	5.86e-06	4.29e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PLA2G1B—atherosclerosis	5.81e-06	4.26e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—HMGCR—atherosclerosis	5.78e-06	4.24e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—MTHFR—atherosclerosis	5.78e-06	4.23e-05	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	5.76e-06	4.22e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GSTM1—atherosclerosis	5.75e-06	4.21e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—MAPK3—atherosclerosis	5.75e-06	4.21e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GSTM1—atherosclerosis	5.7e-06	4.18e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—NOS3—atherosclerosis	5.7e-06	4.17e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SOCS3—atherosclerosis	5.67e-06	4.15e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PPARA—atherosclerosis	5.67e-06	4.15e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—MAPK3—atherosclerosis	5.66e-06	4.15e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—LPL—atherosclerosis	5.65e-06	4.13e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—NOS2—atherosclerosis	5.64e-06	4.13e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ALOX5—atherosclerosis	5.61e-06	4.11e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—LPL—atherosclerosis	5.6e-06	4.1e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—MTHFR—atherosclerosis	5.59e-06	4.09e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GPX1—atherosclerosis	5.51e-06	4.03e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—AGT—atherosclerosis	5.49e-06	4.02e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—INS—atherosclerosis	5.49e-06	4.02e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PPARA—atherosclerosis	5.48e-06	4.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MMP3—atherosclerosis	5.48e-06	4.01e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GPX1—atherosclerosis	5.46e-06	4e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IGF2—atherosclerosis	5.46e-06	3.99e-05	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	5.4e-06	3.95e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—APOE—atherosclerosis	5.38e-06	3.94e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CD36—atherosclerosis	5.37e-06	3.93e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CAV1—atherosclerosis	5.33e-06	3.9e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CD36—atherosclerosis	5.32e-06	3.89e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—APOA1—atherosclerosis	5.32e-06	3.89e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—AGT—atherosclerosis	5.31e-06	3.89e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—APOB—atherosclerosis	5.3e-06	3.88e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PTGS2—atherosclerosis	5.21e-06	3.82e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—EDN1—atherosclerosis	5.21e-06	3.82e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—APOE—atherosclerosis	5.2e-06	3.81e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCL5—atherosclerosis	5.17e-06	3.79e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—INS—atherosclerosis	5.17e-06	3.79e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ABCA1—atherosclerosis	5.16e-06	3.78e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CAV1—atherosclerosis	5.15e-06	3.77e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—APOA1—atherosclerosis	5.14e-06	3.77e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ABCG1—atherosclerosis	5.12e-06	3.75e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—MTHFR—atherosclerosis	5.08e-06	3.72e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—LPL—atherosclerosis	5.06e-06	3.7e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—SERPINE1—atherosclerosis	5.04e-06	3.69e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—MTHFR—atherosclerosis	5.04e-06	3.69e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—NAMPT—atherosclerosis	5.03e-06	3.69e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—LIPC—atherosclerosis	5e-06	3.66e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PPARA—atherosclerosis	4.99e-06	3.65e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—APOC3—atherosclerosis	4.97e-06	3.64e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PPARA—atherosclerosis	4.94e-06	3.62e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—LDLR—atherosclerosis	4.94e-06	3.62e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PRKCG—atherosclerosis	4.92e-06	3.6e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CG—atherosclerosis	4.85e-06	3.55e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—AGT—atherosclerosis	4.83e-06	3.54e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CETP—atherosclerosis	4.83e-06	3.53e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—LCAT—atherosclerosis	4.81e-06	3.52e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—FABP4—atherosclerosis	4.81e-06	3.52e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NOS3—atherosclerosis	4.81e-06	3.52e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SPP1—atherosclerosis	4.79e-06	3.51e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—AGT—atherosclerosis	4.79e-06	3.51e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CXCL8—atherosclerosis	4.77e-06	3.49e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—IL6—atherosclerosis	4.76e-06	3.48e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—SERPINE1—atherosclerosis	4.75e-06	3.48e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	4.74e-06	3.47e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—APOE—atherosclerosis	4.73e-06	3.47e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—APOA4—atherosclerosis	4.72e-06	3.46e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CG—atherosclerosis	4.7e-06	3.44e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—APOE—atherosclerosis	4.69e-06	3.44e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CAV1—atherosclerosis	4.69e-06	3.43e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IFNG—atherosclerosis	4.69e-06	3.43e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PPARG—atherosclerosis	4.69e-06	3.43e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—APOA1—atherosclerosis	4.68e-06	3.43e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CAV1—atherosclerosis	4.65e-06	3.4e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP7A1—atherosclerosis	4.64e-06	3.4e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—APOA1—atherosclerosis	4.64e-06	3.4e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SCARB1—atherosclerosis	4.62e-06	3.38e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—INS—atherosclerosis	4.6e-06	3.36e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—NOS3—atherosclerosis	4.54e-06	3.32e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PPARG—atherosclerosis	4.53e-06	3.32e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—INS—atherosclerosis	4.44e-06	3.25e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PDGFB—atherosclerosis	4.43e-06	3.25e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—HMOX1—atherosclerosis	4.42e-06	3.24e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTGS2—atherosclerosis	4.4e-06	3.22e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—AKT1—atherosclerosis	4.39e-06	3.21e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—HMGCR—atherosclerosis	4.37e-06	3.2e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AGT—atherosclerosis	4.33e-06	3.17e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP27A1—atherosclerosis	4.29e-06	3.14e-05	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	4.28e-06	3.13e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CG—atherosclerosis	4.27e-06	3.13e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—LEP—atherosclerosis	4.24e-06	3.1e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—APOE—atherosclerosis	4.24e-06	3.1e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—APOB—atherosclerosis	4.24e-06	3.1e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CG—atherosclerosis	4.23e-06	3.1e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ALB—atherosclerosis	4.21e-06	3.08e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—IL6—atherosclerosis	4.2e-06	3.08e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CAV1—atherosclerosis	4.2e-06	3.08e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—APOA1—atherosclerosis	4.19e-06	3.07e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL1B—atherosclerosis	4.18e-06	3.06e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTGS2—atherosclerosis	4.15e-06	3.04e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL6—atherosclerosis	4.14e-06	3.03e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PPARG—atherosclerosis	4.12e-06	3.02e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GSTM1—atherosclerosis	4.12e-06	3.02e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PPARG—atherosclerosis	4.09e-06	2.99e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ALB—atherosclerosis	4.07e-06	2.98e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—APOA2—atherosclerosis	4.07e-06	2.98e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ALOX15—atherosclerosis	4.07e-06	2.98e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	4.07e-06	2.98e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	4.07e-06	2.98e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ESR1—atherosclerosis	4.05e-06	2.96e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—LPL—atherosclerosis	4.05e-06	2.96e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—INS—atherosclerosis	4.04e-06	2.96e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—NOS3—atherosclerosis	4.03e-06	2.95e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ABCG5—atherosclerosis	4.02e-06	2.94e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—INS—atherosclerosis	4.01e-06	2.93e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—F2—atherosclerosis	4e-06	2.93e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GPX1—atherosclerosis	3.95e-06	2.89e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—NFKB1—atherosclerosis	3.9e-06	2.86e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—NOS3—atherosclerosis	3.9e-06	2.85e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ABCA1—atherosclerosis	3.89e-06	2.85e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—LPA—atherosclerosis	3.88e-06	2.84e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—AKT1—atherosclerosis	3.88e-06	2.84e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CD36—atherosclerosis	3.84e-06	2.81e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MAPK8—atherosclerosis	3.83e-06	2.81e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CG—atherosclerosis	3.83e-06	2.8e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—AKT1—atherosclerosis	3.82e-06	2.8e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—BGN—atherosclerosis	3.76e-06	2.75e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—AKT1—atherosclerosis	3.72e-06	2.73e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—APOA5—atherosclerosis	3.72e-06	2.72e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ALB—atherosclerosis	3.71e-06	2.71e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PTGS2—atherosclerosis	3.69e-06	2.7e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ALB—atherosclerosis	3.67e-06	2.69e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—MAPK3—atherosclerosis	3.66e-06	2.68e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—MTHFR—atherosclerosis	3.64e-06	2.67e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—INS—atherosclerosis	3.62e-06	2.65e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	3.58e-06	2.62e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PPARA—atherosclerosis	3.57e-06	2.62e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PTGS2—atherosclerosis	3.56e-06	2.61e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCL2—atherosclerosis	3.56e-06	2.61e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—NOS3—atherosclerosis	3.55e-06	2.6e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—NOS3—atherosclerosis	3.51e-06	2.57e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—STAT3—atherosclerosis	3.5e-06	2.57e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IGF1—atherosclerosis	3.5e-06	2.56e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—AGT—atherosclerosis	3.46e-06	2.53e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ALOX5—atherosclerosis	3.46e-06	2.53e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—STAT3—atherosclerosis	3.43e-06	2.51e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—APOE—atherosclerosis	3.39e-06	2.48e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CAV1—atherosclerosis	3.36e-06	2.46e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—APOA1—atherosclerosis	3.35e-06	2.45e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MAPK3—atherosclerosis	3.35e-06	2.45e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—HMOX1—atherosclerosis	3.34e-06	2.44e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SERPINE1—atherosclerosis	3.33e-06	2.44e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MAPK3—atherosclerosis	3.28e-06	2.4e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PTGS2—atherosclerosis	3.24e-06	2.37e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—STAT3—atherosclerosis	3.24e-06	2.37e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PTGS2—atherosclerosis	3.21e-06	2.35e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—APOB—atherosclerosis	3.2e-06	2.34e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—TGFB1—atherosclerosis	3.18e-06	2.33e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NOS3—atherosclerosis	3.18e-06	2.33e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GSTM1—atherosclerosis	3.11e-06	2.28e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NAMPT—atherosclerosis	3.1e-06	2.27e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MAPK3—atherosclerosis	3.09e-06	2.26e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—LIPC—atherosclerosis	3.08e-06	2.26e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—APOC3—atherosclerosis	3.06e-06	2.24e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CG—atherosclerosis	3.06e-06	2.24e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—LPL—atherosclerosis	3.05e-06	2.24e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—LDLR—atherosclerosis	3.04e-06	2.23e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—TGFB1—atherosclerosis	3e-06	2.2e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GPX1—atherosclerosis	2.98e-06	2.18e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CETP—atherosclerosis	2.97e-06	2.18e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PPARG—atherosclerosis	2.95e-06	2.16e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CD36—atherosclerosis	2.9e-06	2.12e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—INS—atherosclerosis	2.9e-06	2.12e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SCARB1—atherosclerosis	2.85e-06	2.09e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CXCL8—atherosclerosis	2.82e-06	2.06e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—MTHFR—atherosclerosis	2.75e-06	2.01e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PPARA—atherosclerosis	2.7e-06	1.97e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—HMGCR—atherosclerosis	2.69e-06	1.97e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL6—atherosclerosis	2.68e-06	1.96e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ALB—atherosclerosis	2.66e-06	1.94e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—AKT1—atherosclerosis	2.62e-06	1.92e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AGT—atherosclerosis	2.61e-06	1.91e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—APOE—atherosclerosis	2.56e-06	1.87e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MMP9—atherosclerosis	2.55e-06	1.87e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—NOS3—atherosclerosis	2.54e-06	1.86e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CAV1—atherosclerosis	2.54e-06	1.86e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—APOA1—atherosclerosis	2.53e-06	1.85e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NFKB1—atherosclerosis	2.52e-06	1.85e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MAPK8—atherosclerosis	2.48e-06	1.81e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—AKT1—atherosclerosis	2.47e-06	1.81e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL6—atherosclerosis	2.45e-06	1.79e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—IL6—atherosclerosis	2.4e-06	1.76e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ABCA1—atherosclerosis	2.4e-06	1.76e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTGS2—atherosclerosis	2.32e-06	1.7e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CG—atherosclerosis	2.31e-06	1.69e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—VEGFA—atherosclerosis	2.29e-06	1.68e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—STAT3—atherosclerosis	2.27e-06	1.66e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—IL6—atherosclerosis	2.26e-06	1.65e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—AKT1—atherosclerosis	2.26e-06	1.65e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PPARG—atherosclerosis	2.23e-06	1.63e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—AKT1—atherosclerosis	2.21e-06	1.62e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—INS—atherosclerosis	2.19e-06	1.6e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MAPK3—atherosclerosis	2.16e-06	1.58e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TGFB1—atherosclerosis	2.1e-06	1.54e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—AKT1—atherosclerosis	2.08e-06	1.53e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.06e-06	1.51e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ALB—atherosclerosis	2e-06	1.47e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—APOB—atherosclerosis	1.97e-06	1.44e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—NOS3—atherosclerosis	1.92e-06	1.4e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.92e-06	1.4e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—LPL—atherosclerosis	1.88e-06	1.38e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—AKT1—atherosclerosis	1.85e-06	1.36e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GPX1—atherosclerosis	1.84e-06	1.34e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—AKT1—atherosclerosis	1.79e-06	1.31e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CD36—atherosclerosis	1.79e-06	1.31e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTGS2—atherosclerosis	1.75e-06	1.28e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.69e-06	1.24e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PPARA—atherosclerosis	1.66e-06	1.22e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—AKT1—atherosclerosis	1.63e-06	1.19e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—AKT1—atherosclerosis	1.62e-06	1.18e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AGT—atherosclerosis	1.61e-06	1.18e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL6—atherosclerosis	1.58e-06	1.16e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—APOE—atherosclerosis	1.58e-06	1.15e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CAV1—atherosclerosis	1.56e-06	1.14e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—APOA1—atherosclerosis	1.56e-06	1.14e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AKT1—atherosclerosis	1.46e-06	1.07e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.42e-06	1.04e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PPARG—atherosclerosis	1.37e-06	1.01e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—INS—atherosclerosis	1.35e-06	9.86e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ALB—atherosclerosis	1.23e-06	9.04e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NOS3—atherosclerosis	1.18e-06	8.65e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—AKT1—atherosclerosis	1.17e-06	8.55e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.08e-06	7.91e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AKT1—atherosclerosis	8.81e-07	6.45e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AKT1—atherosclerosis	5.43e-07	3.98e-06	CbGpPWpGaD
